A detailed history of Woodline Partners LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Woodline Partners LP holds 750,950 shares of OCUL stock, worth $9.37 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
750,950
Previous 750,950 -0.0%
Holding current value
$9.37 Million
Previous $5.5 Million 26.6%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$5.93 - $9.08 $1.49 Million - $2.28 Million
-251,485 Reduced 25.09%
750,950 $5.5 Million
Q4 2024

Feb 14, 2025

BUY
$8.33 - $11.47 $20,283 - $27,929
2,435 Added 0.24%
1,002,435 $8.56 Million
Q3 2024

Nov 14, 2024

BUY
$6.45 - $9.23 $6.45 Million - $9.23 Million
1,000,000 New
1,000,000 $8.7 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $961M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.